EU ready to discuss COVID vaccine patent waiver, says Ursula von der Leyen
SECTIONS
Last Updated: May 06, 2021, 04:03 PM IST
Share
Synopsis
The head of the EU executive said the bloc s vaccination effort was accelerating, with 30 Europeans inoculated per second, while exporting more than 200 million vaccine doses to the rest of the world.
AP
In pic: European Commission President Ursula von der Leyen
The European Union is willing to discuss a proposal, now backed by the United States, to waive intellectual property rights for COVID-19 vaccines, European Commission president Ursula von der Leyen said on Thursday. The head of the EU executive said the bloc s vaccination effort was accelerating, with 30 Europeans inoculated per second, while exporting more than 200 million vaccine doses to the rest of the world.
EuropeEU ready to discuss COVID vaccine patent waiver, says von der Leyen
Reuters
2 minute read
European Commission President Ursula von der Leyen removes her mask while meeting with Jordan s King Abdullah II ibn Al Hussein (not pictured) in Brussels, Belgium May 5, 2021. REUTERS/Yves Herman/Pool
The European Union is willing to discuss a proposal, now backed by the United States, to waive intellectual property rights for COVID-19 vaccines, European Commission president Ursula von der Leyen said on Thursday.
The head of the EU executive said the bloc s vaccination effort was accelerating, with 30 Europeans inoculated per second, while exporting more than 200 million vaccine doses to the rest of the world.
by Tyler Durden
Just after Pfizer reported blockbuster quarterly profits,
Gates has vigorously opposed the waiver, and by backing it,
the White House has effectively helped to validate Gates s critics, like the New Republic, who have accused him of putting profits before people s lives.
Now, European Commission President Ursula von der Leyen has announced that the EU is considering joining the US in supporting the waiver proposal, which was put forth by India and South Africa.
The head of the EU s unelected executive body said the bloc s vaccination effort was accelerating, with 30 Europeans inoculated per second as of Wednesday, while exporting more than 200MM vaccine doses to the rest of the world. She added that the bloc is ready to discuss supporting the waiver - though of course no final decision of support has been made.
WRAPUP 3-EU supports COVID vaccine patent waiver talks, but critics say won t solve scarcity Reuters 7 hrs ago
(Adds U.S. secretary of state, analyst comment, details on shortcomings of plan; updates shares) U.S. says waiver would increase vaccine manufacturing Critics say patent restrictions not responsible for scarcity Drugmaker stocks mostly recover after sharp drop
By Philip Blenkinsop and Carl O Donnell
BRUSSELS/NEW YORK, May 6 (Reuters) - The European Union on Thursday backed a U.S. proposal to discuss waiving patent protections for COVID-19 vaccines, but drugmakers and some other governments opposed the idea, saying it would not solve global inoculation shortages.
EU willing to discuss Covid vaccine patent waiver thenationalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenationalnews.com Daily Mail and Mail on Sunday newspapers.